Recent studies using a p110δ-selective inhibitor in a mouse model of rheumatoid arthritis showed that p110δ plays an anti-inflammatory role in synoviocytes through inhibition of Akt/PKB activation, induced by platelet-derived growth factor and tumour necrosis factor α (TNFα) [44]. The gene discussed is PIK3CD; the disease is rheumatoid arthritis.